Bicara Therapeutics Inc.
BCAX
$26.87
$0.532.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 539.75M | 414.80M | 290.17M | 436.61M | 462.07M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.16M | 7.25M | 7.21M | 7.79M | 8.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 544.92M | 422.05M | 297.37M | 444.39M | 470.75M |
|
|
|||||
| Total Current Assets | 544.92M | 422.05M | 297.37M | 444.39M | 470.75M |
| Net Property, Plant & Equipment | 1.77M | 2.03M | 2.10M | 2.35M | 688.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.91M | 6.91M | 7.80M | 6.84M | 6.64M |
| Total Assets | 553.60M | 430.99M | 424.69M | 453.59M | 478.08M |
|
|
|||||
| Total Accounts Payable | 7.44M | 5.52M | 3.66M | 2.91M | 2.74M |
| Total Accrued Expenses | 30.76M | 22.32M | 16.27M | 13.24M | 15.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.14M | 1.12M | 1.10M | 1.07M | 591.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 39.34M | 28.95M | 21.03M | 17.23M | 19.12M |
|
|
|||||
| Total Current Liabilities | 39.34M | 28.95M | 21.03M | 17.23M | 19.12M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 301.00K | 593.00K | 880.00K | 1.16M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 39.64M | 29.54M | 21.91M | 18.39M | 19.12M |
|
|
|||||
| Common Stock & APIC | 929.38M | 760.18M | 724.50M | 720.45M | 716.82M |
| Retained Earnings | -415.18M | -358.97M | -321.58M | -285.25M | -257.86M |
| Treasury Stock & Other | -243.00K | 243.00K | -136.00K | -- | -- |
| Total Common Equity | 513.96M | 401.45M | 402.78M | 435.20M | 458.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 513.96M | 401.45M | 402.78M | 435.20M | 458.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 513.96M | 401.45M | 402.78M | 435.20M | 458.96M |
|
|
|||||